An overview of the compounding pharmacy framework in Australia, how it is regulated, and why the source of a therapeutic compound matters for safety.
Important: This page is general educational information only and does not constitute medical advice. Many therapeutic compounds available through compounding pharmacies are prescription-only medicines in Australia. Always consult a qualified, AHPRA-registered medical practitioner before making any decisions about your health.
Compounding pharmacies are a recognised and regulated part of the Australian pharmaceutical system. Understanding how they work, what regulatory framework governs them, and why they differ from unregulated sources is relevant for anyone trying to understand the therapeutic goods landscape in Australia.
A compounding pharmacy prepares customised medications that are not available as standard commercial products. Rather than dispensing a pre-manufactured medicine, a compounding pharmacy prepares a specific formulation in a specific concentration or delivery form based on a valid prescription from a licensed medical practitioner.
Compounding has a long history in Australian pharmacy practice. It allows doctors to prescribe formulations tailored to individual patient needs, including different concentrations, delivery forms such as creams, capsules or injectables, or combinations not available in commercial products. The compounding pharmacist prepares the medicine fresh for the specific prescription rather than dispensing a pre-packaged commercial product.
In Australia, compounding pharmacies are regulated under the Therapeutic Goods Act and must hold appropriate licences issued by the TGA. The relevant standard for compounding practice is the TGA's Current Good Manufacturing Practice (cGMP) guidelines as they apply to compounding, as well as state and territory pharmacy regulatory requirements.
A licensed compounding pharmacy is required to use pharmaceutical-grade ingredients sourced from approved suppliers, operate under quality-controlled conditions with documented processes, compound only against valid prescriptions from licensed practitioners, and maintain records of preparation and dispensing. These requirements are what distinguish a licensed Australian compounding pharmacy from unregulated domestic or overseas sources.
Pharmaceutical-grade vs. unregulated: The term "pharmaceutical-grade" refers to ingredients that meet established purity and potency standards set by official pharmacopoeias. Products sourced from unregulated online suppliers have not been verified against these standards. Independent testing of unregulated peptide products has found significant variation in actual contents relative to label claims, including contamination, incorrect concentrations, and in some cases the absence of the claimed active ingredient.
The TGA's April 2026 safety alert on peptide products specifically noted that the adverse events reported, including hospitalisation, severe allergic reactions, and other serious outcomes, were associated with products sourced outside the regulated compounding pharmacy framework. Products from unregulated sources have not been prepared under pharmaceutical quality standards, have not been evaluated for purity or sterility, and in some cases may not contain what the label states.
The distinction between a product prepared by a licensed compounding pharmacy under TGA-regulated conditions and a product sourced from an unregulated online supplier is not a minor difference in branding or price. It is a fundamental difference in what the product actually is and what guarantees exist about its contents.
TGA safety alert, April 2026: The TGA reported receiving notifications of severe adverse events associated with unregulated peptide products, including severe allergic reactions leading to hospitalisation, severe inflammation, palpitations, pain, insomnia and blurred vision. These products had not been evaluated for safety, quality or effectiveness. Full details at www.tga.gov.au.
A licensed compounding pharmacy can only dispense against a valid prescription from an AHPRA-registered medical practitioner. This is a legal requirement under the Therapeutic Goods Act for Schedule 4 prescription medicines. A prescription can only be issued following a clinical assessment of the individual patient by the prescribing doctor.
This means the legitimate pathway for accessing a compounded prescription medicine involves a qualified doctor assessing whether that compound is appropriate for that individual, writing a prescription if it is, and the compounding pharmacy preparing and dispensing it against that prescription. Products available without this pathway are not operating within the legal framework.
The following official sources provide authoritative information on compounding pharmacies, prescription medicines, and therapeutic goods regulation in Australia:
This article is general educational information only. Nothing on this page constitutes medical advice or a recommendation to seek, obtain or purchase any therapeutic compound. Always consult a qualified, AHPRA-registered medical practitioner before making decisions about your health. For the TGA's current guidance on compounding and prescription medicines, visit www.tga.gov.au.